TLDR: Siemens Healthineers India Global Competence Center (GCC) is significantly expanding its deeptech partnerships with Indian startups, leveraging Bengaluru as a key innovation hub. This collaboration aims to integrate advanced technologies like AI, digital twins, and immersive tech into healthcare solutions, focusing on improving access to care, diagnostics, and therapy across various disease areas. The initiative underscores India’s growing importance in Siemens Healthineers’ global innovation strategy.
Bengaluru, India – Siemens Healthineers India Global Competence Center (GCC) is intensifying its strategic deeptech partnerships with a diverse array of Indian startups, marking a significant step in advancing healthcare innovation. This collaboration is poised to deliver cutting-edge healthcare solutions by harnessing the specialized expertise of India’s vibrant startup ecosystem.
Siemens Healthineers, a global medtech leader with a legacy spanning over 125 years, is continuously seeking technological breakthroughs in healthcare. Bengaluru has emerged as a crucial nexus for this pursuit, serving as one of the company’s four global innovation hubs. The Bengaluru GCC is equipped with extensive capabilities in critical areas such as data analytics, artificial intelligence (AI), immersive technologies like augmented and virtual reality (AR/VR), user experience (UX) design, and cybersecurity.
The rationale behind these deepening partnerships is clear: Indian deeptech startups bring specialized expertise in emerging technologies, while Siemens Healthineers contributes invaluable experience and global market reach, creating a highly complementary synergy. This collaboration is particularly fueled by the increasing convergence between medtech and advanced technologies, including Generative AI (GenAI), digital twins, robotics, sensors, and immersive technologies. The objective is to fully leverage these relationships to foster breakthrough ideas and fresh thinking within the healthcare ecosystem.
Kalavathi GV, Executive Director and Head of Global Development Center, Siemens Healthineers, emphasized the importance of this approach, stating, “Working closely with the startup ecosystem is a key part of how we envision advancing healthcare through new technologies and business models.”
These collaborations are structured around six core domains: enhancing access to care, fostering networked care, developing digitally-enabled services, advancing radiology imaging, improving in-vitro diagnostics, and pioneering advanced image-guided therapy. The ultimate goal is to improve care in critical disease areas such as cardiology, neurology, oncology, and infectious diseases. Startups engaging with Siemens Healthineers benefit significantly from access to mentorship, global platforms, proprietary software, and essential equipment, enabling them to build, test, and scale their solutions more rapidly and effectively.
India’s strategic importance to Siemens Healthineers extends beyond these partnerships. As per CEO Bernd Montag, ‘every single Siemens Healthineers product now has ‘India inside of it’,’ highlighting the profound impact of the 7,000 Healthineers based in the country. The company is also making substantial investments, including €160 million (approximately ₹1,300 crore) towards its Bengaluru Development Centre, which is on target for a 2025 opening. Furthermore, Siemens Healthineers plans to expand its Indian team by 900 to 1,200 new members over the next 12 to 18 months, evolving from local to global solution development.
Also Read:
- Karnataka and Berlin Forge Strategic Alliance for Global Startup and AI Innovation
- AIC-BIMTECH and Google Collaborate to Empower Over 150 Startups with AI
In a notable example of this commitment, Siemens Healthineers has partnered with the Indian Institute of Science (IISc) to launch a collaborative AI laboratory in Bangalore, dedicated to precision medicine. This initiative involves an investment of INR 10 million over five years and focuses on developing open-source AI tools for automating the segmentation of pathological findings in neuroimaging data, aiming to improve the diagnosis and population-level analysis of neurological diseases. The laboratory also supports M.Tech fellowships for women, promoting greater female representation in AI.
